About Caroline Xie
Caroline Xie is a director at DexCare.
Form D filings also name Caroline Xie as a director at Twin Health.
Caroline Xie first appears on SEC filings in 2021.
Experience
This experience comes from Caroline Xie's profile and from SEC filings. For roles taken from filings, the years are when the filings name Caroline Xie in the role, so the role may have started earlier or lasted longer.
PM
Parabilis Medicines Current
Investor
2026 – Present
OP
OpenEvidence Current
Investor
2025 – Present
ST
Strand Therapeutics Current
Investor
2025 – Present
AS
Assured Current
Investor
2024 – Present
DexCare, Inc. Current
Investor (2023 – Present)
Director
2023 – Present · Seattle, WA
Patient navigation and scheduling software for health systems.
AI
Apprentice.io Current
Investor
2023 – Present
Twin Health, Inc. Current
Investor (2021 – Present)
Director
2021 – Present · Menlo Park, CA
Metabolic health programs for employees and health plan members.
DH
Devoted Health Current
Investor
2021 – Present
KH
Komodo Health Current
Investor
2021 – Present
RH
Reify Health Current
Investor
2021 – Present
NA
Nayya Current
Investor
2021 – Present
UU
Unite Us Current
Investor
2021 – Present
NO
Notable Current
Investor
2021 – Present
BE
Benchling Current
Investor
2020 – Present
RS
Restaurant365 Software Current
Investor
2019 – Present
GI
GitLab Inc. Current
Investor
2018 – Present
BA
Braze (formerly Appboy) Current
Investor
2017 – Present
DA
Datadog Current
Investor
2016 – Present
RE
Relativity Current
Investor
2015 – Present
IC
ICONIQ Current
General Partner, ICONIQ
2013 – Present
Key Colleagues at Startups
The people Caroline Xie works with at each company, as listed on that company's latest Form D.
Twin Health, Inc. · Form D, Sep 16, 2026
Jahangir Mohammed
Founder & CEO, director
Ravi Lambah
Head, Strategic Initiatives, Temasek and director
Bruce Dunlevie
Founder and director
Mohit Bhatnagar
Managing Director, Sequoia India
Jennifer Bealer
Chief Legal Officer
Tom Samuelson
Chief Financial Officer
Kevin Johnson
Former CEO/President, Starbucks and director
DC
Delos Cosgrove
Director
DexCare, Inc. · Form D, Sep 14, 2026
PM
Paul Minardi
Director
TC
Toby Cosgrove
Director
BF
Branden Fini
Director
MB
Matthew Blosl
Chief Executive Officer and director
Todd Cozzens
Managing Partner, Transformation Capital and director
LK
Lynne Chou O'Keefe
Director